Genetic Drivers,Risk Factors and Management Strategies on Survival and Clinical Outcomes in Visceral Venous "Thrombosis"
Thrombosis
Impact of Genetic Drivers, Acquired Risk Factors, and Management Strategies on Survival and Clinical Outcomes in Visceral Venous Thrombosis
1 other identifier
observational
101
1 country
1
Brief Summary
This study aims to evaluate the impact of genetic drivers (somatic and inherited thrombophilias), acquired risk factors, and management strategies on survival and clinical outcomes in patients with VVT using a hybrid prospective-retrospective cohort design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2025
CompletedFirst Submitted
Initial submission to the registry
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 14, 2026
January 9, 2026
January 1, 2026
1 year
December 23, 2025
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Patients diagnosed with visceral venous thrombosis
To evaluate the impact of genetic drivers (somatic and inherited thrombophilias), acquired risk factors, and management strategies on survival and clinical outcomes in patients with VVT using a hybrid prospective-retrospective cohort design.
The retrospective component will include eligible patients diagnosed within the preceding ten years, whereas the prospective component will enroll newly diagnosed patients and follow them for one year.
Secondary Outcomes (1)
Frequency and distribution
The retrospective component will include eligible patients diagnosed within the preceding ten years, whereas the prospective component will enroll newly diagnosed patients and follow them for one year.
Study Arms (2)
Retrospective Cohort Analysis
Review of medical records to analyze demographic, clinical, and molecular data. Assessment of treatment regimens and outcomes, including thrombotic events, disease progression, and survival rates.
Prospective Cohort Analysis
Consecutive patients will be diagnosed with VVT from \[date of ethical approval\] forward, enrolled at diagnosis and followed prospectively with standardized baseline testing (including comprehensive genetic panel) and predefined follow-up visits.
Interventions
Radiological intervention Basic laboratory investigations, and Thrombophilia diagnosis
Eligibility Criteria
Patients diagnosed with visceral venous thrombosis, including portal, mesenteric, splenic, renal and hepatic vein thrombosis in Department of Internal Medicine, Sohag University Hospital.
You may qualify if:
- Adult patients (≥ 18 years) with radiologically confirmed visceral venous thrombosis.
- Availability of complete clinical, laboratory, and imaging data at diagnosis.
- Patients who consent to participate and provide blood samples for genetic testing.
You may not qualify if:
- Isolated lower-limb deep-vein thrombosis or pulmonary embolism without visceral involvement.
- Patients with incomplete records precluding outcome assessment.
- Refusal or inability to provide informed consent
- Patients lost to follow-up within the first three months of diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, 82511, Egypt
Related Publications (2)
Boccatonda A, Gentilini S, Zanata E, Simion C, Serra C, Simioni P, Piscaglia F, Campello E, Ageno W. Portal Vein Thrombosis: State-of-the-Art Review. J Clin Med. 2024 Mar 6;13(5):1517. doi: 10.3390/jcm13051517.
PMID: 38592411BACKGROUNDCohen O, Caiano LM, Tufano A, Ageno W. Cancer-Associated Splanchnic Vein Thrombosis. Semin Thromb Hemost. 2021 Nov;47(8):931-941. doi: 10.1055/s-0040-1722607. Epub 2021 Jun 11.
PMID: 34116580BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mahmoud I Yousef, Associate Prof.
Sohag University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 23, 2025
First Posted
January 9, 2026
Study Start
December 14, 2025
Primary Completion (Estimated)
December 14, 2026
Study Completion (Estimated)
December 14, 2026
Last Updated
January 9, 2026
Record last verified: 2026-01